LMO2 and gene therapy for severe combined immunodeficiency
- PMID: 15190153
- DOI: 10.1056/NEJM200406103502422
LMO2 and gene therapy for severe combined immunodeficiency
Comment on
-
Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.N Engl J Med. 2004 Feb 26;350(9):913-22. doi: 10.1056/NEJMra032207. N Engl J Med. 2004. PMID: 14985489 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical